Shinichi Ogata
Overview
Explore the profile of Shinichi Ogata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsunaga T, Tominaga N, Ogata S
Dig Endosc
. 2024 Nov;
37(3):300-301.
PMID: 39582398
No abstract available.
2.
Kakiuchi T, Matsuo M, Endo H, Sakata Y, Esaki M, Noda T, et al.
J Gastroenterol
. 2022 Dec;
58(3):196-204.
PMID: 36528706
Background: Vonoprazan (VPZ)-based regimen for Helicobacter pylori (H. pylori) is safe and more efficacious than the proton pump inhibitor-based regimen mainly in adults. This study aimed to evaluate the efficacy...
3.
Imai N, Takeyoshi M, Aizawa S, Tsurumaki M, Kurosawa M, Toyoda A, et al.
J Appl Toxicol
. 2021 Dec;
42(6):1029-1043.
PMID: 34927266
Demands for the elimination and replacement of animal experiments for cosmetic safety assessment have increased in recent years. Evaluation of skin sensitization, however, is a critical issue in cosmetic safety...
4.
Yamaguchi D, Tominaga N, Miyahara K, Tsuruoka N, Sakata Y, Takeuchi Y, et al.
Can J Gastroenterol Hepatol
. 2021 Jun;
2021:6672440.
PMID: 34095017
Background And Aims: The present study aimed to clarify the safety and efficacy of the noncessation method of antithrombotic agents after emergency endoscopic hemostasis in patients with nonvariceal upper gastrointestinal...
5.
Yamaguchi D, Hidaka H, Matsunaga T, Akutagawa T, Tanaka Y, Jubashi A, et al.
Dig Endosc
. 2021 May;
34(1):171-179.
PMID: 33971037
Background And Aim: Elobixibat is a novel ileal bile acid transporter inhibitor. This study aimed to compare the efficacy, tolerability, and safety of the combination of elobixibat and 1 L...
6.
Imai N, Takeyoshi M, Aizawa S, Tsurumaki M, Kurosawa M, Toyoda A, et al.
J Toxicol Sci
. 2021 May;
46(5):235-248.
PMID: 33952800
There has been an increased demand to eliminate animal experiments and to replace the experiments with alternative tests for assessing the safety of cosmetics. The SH test is an in...
7.
Kakiuchi T, Matsuo M, Endo H, Sakata Y, Esaki M, Noda T, et al.
Helicobacter
. 2020 Dec;
26(2):e12776.
PMID: 33368891
Background: The screening and treatment of Helicobacter pylori infection for all junior high students in Saga Prefecture, Japan, were started in 2016. The present study aims to evaluate the influence...
8.
Tominaga N, Ogata S, Esaki M
JGH Open
. 2020 Dec;
4(6):1244-1245.
PMID: 33319068
A 79-year-old female patient receiving maintenance hemodialysis was referred to our hospital because of massive hematochezia. Abdominal enhanced computed tomography (CT) demonstrated extravasation of contrast medium in the descending colon....
9.
Hiraki M, Tanaka T, Kanai T, Shimamura T, Ikeda O, Yasunaga M, et al.
Int J Surg Case Rep
. 2020 Oct;
75:483-487.
PMID: 33076201
Introduction: Rectovaginal fistula (RVF) is a refractory complication that occurs after anastomotic leakage following low anterior resection for rectal disease. Due to its refractory nature, RVF is often managed with...
10.
Sugiyama M, Ueki T, Ogata S, Itagaki H
J Toxicol Sci
. 2019 Jun;
44(6):393-403.
PMID: 31167989
To predict the results of a 24-hr closed human patch test, we previously recommended the use of in vitro test with a reconstructed human epidermis (RhE) model adopted in OECD...